Antiinflammatory potential of nano‐curcumin as an alternative therapeutic agent for the treatment of mild‐to‐moderate hospitalized COVID‐19 patients in a placebo‐controlled clinical trial-论文-万方医学网

首页> > Antiinflammatory potential of nano‐curcumin as an alternative therapeutic agent for the treatment of mild‐to‐moderate hospitalized COVID‐19 patients in a placebo‐controlled clinical trial

Antiinflammatory potential of nano‐curcumin as an alternative therapeutic agent for the treatment of mild‐to‐moderate hospitalized COVID‐19 patients in a placebo‐controlled clinical trial

导出原文传递

翻译打印收藏纠错

第一作者： Ali Asadirad

作者： Ali Asadirad ^[1] ; Roohangiz Nashibi ; Ali Khodadadi ; Ata A Ghadiri ; Mahvash Sadeghi ; Azam Aminian ; Sajad Dehnavi

作者单位： Ahvaz Jundishapur University of Medical Sciences ^[1]

关键词 coronavirus disease‐2019 curcumin cytokine storm inflammatory cytokines severe acute respiratory syndrome‐coronavirus‐2

发布时间 2022-04-29

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

法律状态公告日	法律状态	法律状态信息

检索历史清除

Antiinflammatory potential of nano‐curcumin as an alternative therapeutic agent for the treatment of mild‐to‐moderate hospitalized COVID‐19 patients in a placebo‐controlled clinical trial

相似文献

同项目论文

相关期刊

检索历史 清除

Antiinflammatory potential of nano‐curcumin as an alternative therapeutic agent for the treatment of mild‐to‐moderate hospitalized COVID‐19 patients in a placebo‐controlled clinical trial

相似文献

同项目论文

相关期刊

检索历史清除